Cancer cells with GA in PIK3CA have been shown to be more susceptible to isoform-specific inhibitors of the PI3K pathway (PI3Ki) in vitro, in vivo, and in patients than tumor  cells with wild-type PIK3CA9–19. This evidence concerns the gene PIK3CA and neoplasm.